GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Epigral Ltd (BOM:543332) » Definitions » Marketable Securities

Epigral (BOM:543332) Marketable Securities : ₹440 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Epigral Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Epigral's Marketable Securities for the quarter that ended in Mar. 2024 was ₹440 Mil.

Epigral's annual Marketable Securities increased from Mar. 2022 (₹0 Mil) to Mar. 2023 (₹191 Mil) and increased from Mar. 2023 (₹191 Mil) to Mar. 2024 (₹440 Mil).


Epigral Marketable Securities Historical Data

The historical data trend for Epigral's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epigral Marketable Securities Chart

Epigral Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Marketable Securities
Get a 7-Day Free Trial - - - 191.14 439.56

Epigral Quarterly Data
Mar18 Mar19 Mar20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 191.14 - 275.55 - 439.56

Epigral Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Epigral  (BOM:543332) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Epigral Marketable Securities Related Terms

Thank you for viewing the detailed overview of Epigral's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Epigral (BOM:543332) Business Description

Traded in Other Exchanges
Address
Corporate Road, 5th Floor, 6th Floor & 7th Floor, Meghmani House, Behind Safal Profitaire, Prahladnagar, Ahmedabad, GJ, IND, 380015
Epigral Ltd Formerly Meghmani Finechem Ltd is a producer of Chlor-Alkali and its Derivatives and specialty chemicals with backward and forward integration facilities. It manufactures Caustic Soda, Caustic Potash, CPVC Resin, Epichlorohydrin, Chlorine, Hydrogen, Chloromethanes, and Hydrogen Peroxide. The company is focused on servicing domestic as well as international markets.

Epigral (BOM:543332) Headlines

No Headlines